Übersetzung für "Filière à fusion directe " (Französisch → Englisch) :

This Directive shall apply to mergers of limited liability companies formed in accordance with the law of a Member State and having their registered office, central administration or principal place of business within the Community, provided at least two of them are governed by the laws of different Member States (hereinafter referred to as cross-border mergers).

If employees have participation rights in one of the merging companies under the circumstances set out in this Directive and, if the national law of the Member State in which the company resulting from the cross-border merger has its registered office does not provide for the same level of participation as operated in the relevant merging companies, including in committees of the supervisory board that have decision-making powers, or does not provide for the same entitlement to exercise rights for employees of establishments resulting from the cross-border merger, the participation of employees in the company resulting from the cross-bor ...[+++]der merger and their involvement in the definition of such rights are to be regulated.

In order to facilitate cross-border merger operations, it should be laid down that, unless this Directive provides otherwise, each company taking part in a cross-border merger, and each third party concerned, remains subject to the provisions and formalities of the national law which would be applicable in the case of a national merger.

BLOOD SAFETY AND SELF-SUFFICIENCY - COUNCIL RESOLUTION "THE COUNCIL OF THE EUROPEAN UNION, RECALLING the Commission communication of 25 May 1993 on blood self- sufficiency in the European Community and its conclusions of 13 December 1993 on that communication; NOTES with interest the Commission communication of 21 December 1994 on blood safety and self-sufficiency in the European Community; REAFFIRMS the need to achieve self-sufficiency in blood and its derivatives in the Member States and in the Community, in particular through cooperation between Member States, in accordance with the principle of voluntary, unpaid blood donations; EMPHASIZES that the efforts to promote the quality and safety of blood collection help to prevent AIDS and ...[+++] other communicable diseases; RECALLS that Directive 89/381/EEC [1] which extends the scope of Directives 65/65/EEC and 75/319/EEC on proprietary medicinal products by laying down special provisions regarding medicines derived from human blood or plasma applies only to these products; AGREES on the need to define a strategy for reinforcing trust in the safety of the blood-transfusion chain and promoting self-sufficiency in the Community; ACCORDINGLY AGREES that, taking full account of the Council of Europe's discussions, the main activities to be undertaken could include: - the development of policies and agreed procedures in the donor-selection process among blood-collection establishments; - the implementation of efficient, validated and reliable screening tests; - the development and use of quality-assessment criteria and good practices regarding the collection, processing and transfusion of blood and blood products and patient follow-up procedures; - development of a haemovigilance system on the basis of existing networks for the collection of epidemiological data related to the blood- transfusion chain; - encouragement of health professionals to make optimal use of blood and blood products; - the establishment of basi ...

This cooperation concerns the Tokamak facilities, plasma physics, fusion technology and fuel for fusion, as well as reactors other than the Tokamaks.

The European approach in fusion research has been through concentration of the efforts on magnetic toroidal confinement, mainly along the so- called Tokamak line, while maintaining a watching brief on other approaches to controlled fusion.